Evidence map›Paper›PMID 33758516›Full record

ArticleInfection and drug resistance2021

Adherence to Multidrug Resistant Tuberculosis Treatment and Case Management in Chongqing, China - A Mixed Method Research Study.

Wei Xing, Rui Zhang, Weixi Jiang, Ting Zhang, Michelle Pender, Jiani Zhou, Jie Pu, Shili Liu, Geng Wang, Yong Chen and 4 more

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Wei Xing *Department of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Rui Zhang *Department of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Weixi Jiang *Duke Kunshan University, Kunshan, Jiangsu, People's Republic of China.ORCID 0000-0002-5643-6255
Ting Zhang *Department of Districts and Counties, Chongqing Institute of TB Prevention and Treatment, Chongqing, People's Republic of China.
Michelle PenderDuke Global Health Institute, Duke University, Durham, NC, USA.
Jiani ZhouDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Jie PuDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Shili LiuDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Geng WangDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Yong ChenDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Jin LiDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
Daiyu HuChongqing Institute of TB Prevention and Treatment, Chongqing, People's Republic of China.
Shenglan TangDuke Global Health Institute, Duke University, Durham, NC, USA.
Ying LiDepartment of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.ORCID 0000-0002-8942-1957
Army Medical University · CNDuke University · USDuke Kunshan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis paper evaluated the treatment adherence for multidrug-resistant tuberculosis (MDR-TB) and MDR-TB case management (MTCM) in Chongqing, China in order to identify factors associated with poor treatment adherence and case management.

methodsSurveys with 132 MDR-TB patients and six in-depth interviews with health care workers (HCWs) from primary health centers (PHC), doctors from MDR-TB designated hospitals and MDR-TB patients were conducted. Surveys collected demographic and socio-economic characteristics, as well as factors associated with treatment and case management. In-depth interviews gathered information on treatment and case management experience and adherence behaviors.

resultsPatient surveys found the two main reasons for poor adherence were negative side-effects from the treatment and busy work schedules. In-depth interviews with key stakeholders found that self-perceived symptom improvement, negative side-effects from treatment and financial difficulties were the main reasons for poor adherence. MDR-TB patients from urban areas, who were unmarried, were female, had migrant status, and whose treatments were supervised by health care workers from primary health clinics, had poorer treatment adherence (P<0.05). Among the MDR-TB patients surveyed, 86.7% received any type of MTCM in general (received any kind of MTCM from HCWs in PHC, MDR-TB designated hospital and centers of disease control/TB dispensaries and 62.50% received MTCM from HCWs in PHC sectors). Patients from suburban areas were more likely to receive both MTCM in general (OR=6.70) and MTCM from HCWs in MDR-TB designated hospitals (OR=2.77), but female patients (OR=0.26) were less likely to receive MTCM from HCWs in PHC sectors, and patients who were not educated about MTCM by TB doctors in designated hospitals were less likely to receive MTCM in general (OR=0.14). Patients who had not been hospitalized were less likely to receive MTCM from HCWs in MDR-TB designated hospitals (OR=0.21).

conclusionStronger MTCM by HCWs in PHC sectors would improve treatment adherence among MDR-TB patients. Community-based patient-centered models of MTCM in PHC sectors and the use of digital health technology could help to improve case management and thereby improve adherence.

Indexed as

adherence behaviorsmanagementmulti-drug-resistant tuberculosistreatment

Identifiers

PMID33758516
PMCPMC7979342
OpenAlexW3137899017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.